JOINTCELL
JOINTCELL, licence 80095037: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- CELLFIRE (5005122 Ontario Limited)
- NPN or DIN-HM
- 80095037
- Status
- Active licence
- Licence date
- 25 October 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Écorce de racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 2500.0 mg Potency : 25.0 % Salicin | 250.0 mg | Not calculated |
| N-(2-Hydroxyéthyl)hexadécanamide Source : Palmitoyléthanolamide | 150.0 mg | Not calculated |
| Boswellia serrata Source : Stem bark oleogum resin Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1250.0 mg Potency : 40.0 % Boswellic acids | 125.0 mg | Not calculated |
| Prunus cerasus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1250.0 mg | 125.0 mg | Not calculated |
| Acide hyaluronique Source : Gallus gallus - Crête | 50.0 mg | Not calculated |
| Curcuminoïdes Source : Curcuma longa - rhizome | 98.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support joint health. White willow is traditionally used in Herbal Medicine for the relief of minor joint pain (due to osteoarthritis).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80095037
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.